scispace - formally typeset
D

David Wilson

Researcher at Burnet Institute

Publications -  662
Citations -  21017

David Wilson is an academic researcher from Burnet Institute. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 69, co-authored 618 publications receiving 18780 citations. Previous affiliations of David Wilson include National Health and Medical Research Council & Semel Institute for Neuroscience and Human Behavior.

Papers
More filters
Journal ArticleDOI

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

Jeremy L. O'Brien, +327 more
- 15 Apr 2000 - 
TL;DR: In this article, a meta-analysis of their results indicated reductions in the risks of deep-vein thrombosis and of pulmonary embolism in various high-risk groups.
Journal ArticleDOI

Using and validating the strategic alignment model

TL;DR: The paper demonstrates that SAM has conceptual and practical value and proposes a practical framework that allows management, particularly technology management, to determine current alignment levels and to monitor and change future alignment as required.
Journal ArticleDOI

Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis.

TL;DR: The aim of this study was to estimate the relative risk of cardiovascular disease (CVD) among people living with HIV (PLHIV) compared with the HIV‐uninfected population.
Journal ArticleDOI

Relation between HIV viral load and infectiousness: a model-based analysis

TL;DR: The analyses suggest that the risk of HIV transmission in heterosexual partnerships in the presence of effective treatment is low but non-zero and that the transmission risk in male homosexual partnerships is high over repeated exposures.
Journal Article

Relation between HIV viral load and infectiousness : a model-based analysis. Commentary

TL;DR: In this paper, the authors used a simple mathematical model to estimate the cumulative risk of HIV transmission from effectively treated HIV-infected patients (HIV RNA <10 copies per mL) over a prolonged period.